Google announce that they are collaborating to improve care and outcomes for people with type 1 and type 2 diabetes

谷歌宣布，他们正在合作，以改善保健和个人成果与1型和2型糖尿病

賽諾菲和生命科學團隊在谷歌今天宣布，他們正在合作，以提高治療和預後的1型和2型糖尿病。此次合作將結對賽諾菲的領導在糖尿病治療和設備與谷歌的專業知識分析，微型電子器件和低功耗芯片設計。該公司將探討如何通過開發新的工具，帶來了眾多以前孤立的部分糖尿病管理，並使得各種新的干預措施，以改善糖尿病護理。這包括健康指標，例如血糖和血紅蛋白A1c水平，患者報告的信息，用藥方案和傳感器裝置。


賽諾菲和生命科學團隊在谷歌將結合各自的專長在科技工作更好的方法來收集，分析和理解信息的影響糖尿病的多種來源。希望的是，它會更容易為患者成功地管理他們的糖尿病，這將減少並發症的風險，改善治療效果並最終降低成本。


“作為糖尿病治療的全球領先者，我們既有的義務和承諾，為患有糖尿病的人的綜合解決方案，”奧利弗Brandicourt，MD，首席執行官，賽諾菲說。 “這一舉措結合了賽諾菲的力量和知識，糖尿病與谷歌的技術和分析領導與改造糖尿病治療的潛在創建首個，其獨一無二的倡議。”


“隨著新技術的湧現提供了病人的健康更持續和實時的視圖，我們可以看到承諾的更加主動和有效的方法來控制糖尿病，”安迪·康拉德，生命科學團隊在谷歌的首席執行官說。 “通過與賽諾菲，我們認為糖尿病管理可以更簡單，更方便，它可以幫助患者達到提高生活質量。”


“我們已經建立的專業知識，提供全面，綜合的解決方案，結合藥品，設備，技術和服務，”saidPascale Witz的執行副總裁，賽諾菲，誰將會導致全球糖尿病和心血管護理業務部在該公司的新的組織結構。 “生命科學團隊在谷歌可以幫助我們改善患者的經驗，成果和更有效地管理醫療費用。”


“我們正在經歷糖尿病的世界性大流行，這是非常令人鼓舞的醫療保健和技術創新者加緊提供刀具的切削刃的挑戰和照顧推進技術，以幫助糖尿病患者管理自己的疾病，全天候，”約翰說Joslin糖尿病中心，這是一個合作夥伴的協作·L·布魯克斯，III，總裁兼CEO。“技術，傳感器，分析和數字解決方案將徹底改變血糖的管理，這將帶來生活質量的提高，降低了並發症的風險，並減少與糖尿病護理相關的成本和壁壘。最後，我衷心希望我們能夠把Joslin糖尿病中心改建為博物館。“


關於糖尿病


糖尿病，或乾脆糖尿病是，當胰腺無法再製造胰島素，或者當身體不能很好地利用所產生的胰島素會發生的一種慢性疾病。胰島素是由行為像鍵讓從吃的食物的葡萄糖通過從血流進入細胞在體​​內產生能量胰腺產生的激素。所有的碳水化合物食物被分解成葡萄糖在血液中。胰島素有助於葡萄糖進入細胞中。[1]


不能夠產生胰島素或用它有效地導致血液中的升高的葡萄糖水平（已知為高血糖症）。在長期的高血糖水平與對身體的損害和各種器官和組織的故障相關聯。[2]


最新版IDF糖尿病圖集，發表了關於世界糖尿病日，估計患有糖尿病的人會從3.82億激增至5.92億人到2035年[3]


關於賽諾菲糖尿病


賽諾菲致力於幫助人們控制糖尿病的複雜挑戰，提供創新，集成化和個性化的解決方案。由來自聆聽和患有糖尿病的人，本公司形成夥伴關係，以提供診斷，治療，服務和設備，包括血糖監測系統，從事有價值的見解驅動。賽諾菲銷售注射，吸入和人口服藥物1型或2型糖尿病。


關於賽諾菲


賽諾菲，全球醫療保健的領導者，發現，開發和銷售重點放在病人的需要治療解決方案。賽諾菲在糖尿病解決方案的核心優勢，人用疫苗，創新藥，消費者保健，新興市場，動物健康和Genzyme公司。賽諾菲已在巴黎（EURONEXT：SAN）和紐約（NYSE：SNY）。


關於生命科學團隊在谷歌


生命科學團隊在谷歌的重點是幫助醫療保健移動從被動到主動。從生物，化學，物理，醫學，電氣工程，計算機科學領域的專業知識相結合，我們正在開發的醫生，可以很容易地融入日常生活和幫助改變的檢測，預防和疾病管理的新技術工具。目前的項目開發包括智能隱形眼鏡微型葡萄糖傳感器;一個nanodiagnostics平台，以幫助早期發現疾病;和Liftware器具的人有震顫。







Sanofi and the life sciences team at Google announced today that they are collaborating to improve care and outcomes for people with type 1 and type 2 diabetes. The collaboration will pair Sanofi's leadership in diabetes treatments and devices with Google's expertise in analytics, miniaturized electronics and low power chip design. The companies will explore how to improve diabetes care by developing new tools that bring together many of the previously siloed pieces of diabetes management and enable new kinds of interventions. This includes health indicators such as blood glucose and hemoglobin A1c levels, patient-reported information, medication regimens and sensor devices.


Sanofi and the life sciences team at Google will combine their respective expertise in science and technology to work on better ways to collect, analyze and understand multiple sources of information impacting diabetes. The hope is that it will be easier for patients to successfully manage their diabetes, which would reduce the risk of complications, improve outcomes and ultimately lower costs.


"As a global leader in diabetes care, we have both an obligation and a commitment to provide integrated solutions for people living with diabetes," said Olivier Brandicourt, MD, Chief Executive Officer, Sanofi. "This initiative combines Sanofi's strength and knowledge in diabetes with Google's leadership in technology and analytics to create a first-of-its-kind initiative with the potential to transform diabetes care."


"With new technologies emerging to provide a more continuous and real-time view of a patient's health, we can see the promise for more proactive and effective ways to control diabetes," said Andy Conrad, CEO of the life sciences team at Google. "Together with Sanofi, we believe diabetes management can be simpler and more convenient, which may help patients achieve an improved quality of life."


"We have built expertise in providing holistic, integrated solutions that combine medicines, devices, technologies and services," saidPascale Witz, Executive Vice President, Sanofi, who will lead the Global Diabetes and Cardiovascular Care Business Unit in the company's new organizational structure. "The life sciences team at Google can help us improve the patient experience, outcomes and manage healthcare costs more effectively."


"We are experiencing a worldwide pandemic of diabetes, and it's very encouraging to see healthcare and technology innovators step up to the challenge of providing cutting edge tools and care advancing technologies to help people with diabetes manage their disease, 24/7," said John L. Brooks, III, President and CEO of Joslin Diabetes Center, which is a partner to the collaboration."Technology, sensors, analytics, and digital solutions will revolutionize how blood sugars are managed, which will deliver improved quality of life, lowering the risk of complications and reducing the costs and barriers associated with diabetes care. Ultimately, I truly hope we're able to turn the Joslin Diabetes Center into a museum."


About Diabetes


Diabetes mellitus, or simply diabetes, is a chronic disease that occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it produces. Insulin is a hormone made by the pancreas that acts like a key to let glucose from the food we eat pass from the blood stream into the cells in the body to produce energy. All carbohydrate foods are broken down into glucose in the blood. Insulin helps glucose get into the cells.[1]


Not being able to produce insulin or use it effectively leads to raised glucose levels in the blood (known as hyperglycemia). Over the long-term high glucose levels are associated with damage to the body and failure of various organs and tissues.[2]


The latest edition IDF Diabetes Atlas, published on World Diabetes Day, estimates that people living with diabetes will surge from 382 million to 592 million people by 2035.[3]


About Sanofi Diabetes


Sanofi strives to help people manage the complex challenge of diabetes by delivering innovative, integrated and personalized solutions. Driven by valuable insights that come from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services, and devices including blood glucose monitoring systems. Sanofi markets injectable, inhaled and oral medications for people with type 1 or type 2 diabetes.


About Sanofi


Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).


About the life sciences team at Google


The life sciences team at Google is focused on helping to move health care from reactive to proactive. Combining expertise from the fields of biology, chemistry, physics, medicine, electrical engineering, computer science, we're developing new technology tools for physicians that can integrate easily into daily life and help transform the detection, prevention, and management of disease. Current projects in development include a smart contact lens with miniaturized glucose sensor; a nanodiagnostics platform to help with early detection of disease; and Liftware utensils for people with tremor.

Diabetes orgs;

American Diabetes Association®

www.diabetes.org/

Diabetes UK – Care. Connect. Campaign. - Diabetes UK

https://www.diabetes.org.uk/

Diabetes UK is the leading UK charity that cares for, connects with and campaigns on behalf of all people affected by diabetes.

Google Research

Internet balloon project

Further Reading

Would a robot replace an estate agent in the future ?

emoov is really moving !

How LG Smart Homes and nest.com are making the best use of IoT

Iconic Building Lincoln House Former Maharajah Palace and US embassy sold to business tycoon $113m

FHFA Adopts Final Rule on 2015-2017 Housing Goals for Fannie Mae and Freddie Mac

How low can you go ? speech by Andy Haldane BoE Chief Economist 

UK inflation slips back to zero BoE rate hike months away

FHFA Adopts Final Rule on 2015-2017 Housing Goals for Fannie Mae and Freddie Mac

Senate votes to suspend Fannie Mae Freddie Mac CEO pay

Mortgage Lenders and Administrators statistics Bank of England Sept 2015

Right to Buy Homes Sales: April to June 2015 England Update 

House price inflation gathers pace as market conditions tighten further August 2015 update

Help to Buy, has helped nearly 120,000 people achieve their aspiration of buying a new home since it was created, latest figures reveal

When building more homes isn't enough in the UK

UK Housing Price Index JULY 2015

Help to Buy Equity Loan scheme  Help to Buy NewBuy statistics Data to 30 June 2015 England

What Jeremy Corbyn's leadership victory may mean for housing policy in the UK

Newly Elected Labour Candidate, for Mayor of London, Sadiq Khan,